Oncology

Patients with BRAF V600E mutant metastatic colorectal cancer (mCRC) derive little benefit from standard therapies and have an extremely poor prognosis…

Cyclin-dependent kinase (CDK) 4/6 inhibitors in combination with endocrine therapy (ET) are considered the standard-of-care treatment for patients…

Up to 80% of patients with cancer are affected by chemotherapy-induced nausea and vomiting (CINV) if the appropriate preventive healthcare…

This Ferring-organised Meet-The-Expert symposium at the European Society of Medical Oncology (ESMO) 2019 meeting aimed to discuss new treatment…

This edition of EMJ Oncology 7.1 offers to the readers a wide range of topics and papers in relation to cancer diagnosis and management…

This review covers the inherent difficulties in stratifying early-stage breast cancer patients with regard to risk of recurrence.

In this review of the 2018 ESMO congress, the breaking news from the event is highlighted, including a feature covering the presidential symposia…

Supplemented by summaries of a selection of ESMO abstract presentations, EMJ’s Oncology eJournal provides a comprehensive summary of the 5 days in Munich…